Side-by-side comparison of AI visibility scores, market position, and capabilities
NASDAQ-listed (WBA) US pharmacy giant with 8,700 stores going private via Sycamore Partners LBO in 2024; major restructuring after 70% stock decline, clinic write-downs, and dividend cuts.
Walgreens Boots Alliance (NASDAQ: WBA) is the largest US pharmacy chain and global pharmacy-led health and wellness company — operating approximately 8,700 Walgreens locations in the US alongside Boots pharmacies in the UK and other international markets, providing prescription medications, over-the-counter health products, beauty items, and health clinic services through the largest drugstore footprint in the US. WBA generated $147 billion in revenue in fiscal year 2024 and serves approximately 9 million customers daily, making it one of the most visited retail destinations in the US.
FY2024 Revenue: $372.8B (+4.2% YoY) | Net income: $4.6B (down from $8.4B) | Operating income: $8.5B (-38% YoY) | Q4 2024: $97.7B | Healthcare benefits segment challenged
CVS Health Corporation is one of the largest healthcare companies in the United States, formed through a series of major acquisitions that transformed CVS Pharmacy — a retail drugstore chain founded in Lowell, Massachusetts in 1963 — into a vertically integrated healthcare enterprise. Key acquisitions include Caremark Rx (pharmacy benefit management, 2007), Aetna (health insurance, $69 billion, 2018), and Oak Street Health (primary care clinics, 2023). CVS Health's model positions the company as a healthcare touchpoint spanning insurance enrollment, prescription management, and clinical care delivery.\n\nCVS Health's segments include Health Care Benefits (Aetna insurance for employer groups, Medicare, and Medicaid), Health Services (Caremark PBM, specialty pharmacy, infusion), and Pharmacy & Consumer Wellness (retail operations). CVS operates 9,000+ pharmacy locations and is expanding MinuteClinic and HealthHUB formats that co-locate clinical services with pharmacy for primary and chronic care management. The company also operates pharmacy-only conversion locations removing front-end retail to concentrate on health services.\n\nCVS Health reported FY2024 revenue of $372.8 billion (+4.2% YoY) with net income of approximately $4.6 billion. Near-term pressure on Aetna's Medicare Advantage business — elevated medical cost ratios from post-pandemic care utilization — has driven benefit redesigns and market exits. Despite these headwinds, CVS Health's vertically integrated model combining PBM leverage, insurance membership, and retail pharmacy access represents a structurally unique healthcare asset at scale.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.